Original Source(s)
Related Content
FDA approves dostarlimab for advanced rectal cancer
The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.
by Mouj Hijazi
October 19, 2026
-
3 min
FDA expands bladder cancer therapy approval
The expansion offers another treatment option for patients with high-grade tumors following BCG failure.
by Mouj Hijazi
October 14, 2026
-
3 min
FDA approves FET-PET agent for glioma
The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.
September 14, 2026
-
2 min
